Influence of methisoprinol on the course of an experimental infection with PPMV-1 in pigeons

• Autorzy: Stenzel T. , Tykalowski B. , Smialek M. , Pestka D. , Koncicki A.
• Języki publikacji: EN

Abstrakty

EN

Aim of the study: In view of the frequent occurrence of immunosuppression in pigeons, which is a consequence of viral infections, studies with the use of a synthetic immunomodulator (methisoprinol) were undertaken to evaluate its impact on the course of an experimental infection with PPMV-1. The aim of the study was to determine the usefulness of methisoprinol for the treatment or prophylaxis of viral infections in pigeons. Materials and Methods: Three groups of 5-week-old pigeons, with 15 birds in each, were used in the experiment. Before the experiment, the birds were tested for the presence of antibodies specific to paramyxovirus, and their sensitivity to PPMV-1 infection was evaluated. The virus had been cultured earlier on SPF chicken embryos of 9-12 days. The pigeons from all three groups were infected intravenously with aparamyxovirus suspension (strain APMV-1/ pigeon/Poland/AR3/95 obtained from the Veterinary Institute in Puławy) at a concentration of LD50 10-7 in 0.1 ml at a dose of 0.1 ml/pigeon. The birds in the experimental groups (B1 and B2) were immunomodulated with methisoprinol administered at a dose of 200 mg/1 kg of body weight. The immunomodulator was administered by intramuscular injection for 3 successive days before (group B1) or three successive days after (group B2) the experimental infection. Pigeons in group K (used as a control) were given water by intramuscular injection for 3 days before and 3 days after infection. On days 4, 8, and 12 after infection, 5 birds from each group were euthanized, and sections of internal organs (lung, kidney, brain), as well as cloacal swabs, were collected to detect viral RNA by the RT-PCR method. Results and discussion: Symptoms were recorded from the first day after infection. Neurological symptoms occurred in birds from all groups: in 100% of pigeons from groups B1 and K, and in 80% of pigeons from group B2. Deaths of birds occurred from day 5 after infection in group B1. In the other groups, deaths were observed from day 6 after infection. The total mortality of the infected birds ranged from 70% (group B2) to 100% (groups B1 and K). The resolution of symptoms was observed from day 6 after infection in pigeons from group B2. During molecular examination, it was noted that the highest number of positive samples (presence of PPMV-1) on each day of the investigation was obtained from brain samples and cloacal swabs. The highest number of positive results in kidney samples was obtained from groups B1 and K on day 4 after infection. On the successive days of the investigation the percentage of positive samples increased to 100 in birds from all groups except group B2. Based On the basis of the results of the present study, it can be concluded that methisoprinol, used at a dose of 200 mg/kg of body weight after infection, has antiviral activity, manifested by a slower development of paramyxovirosis in pigeons infected intravenously with PPMV-1. Therefore, the administration of methisoprinol to naturally infected and diseased birds may be useful in the treatment of viral diseases.

Słowa kluczowe

EN

animal disease; infectious disease; methisoprinol; experimental infection; PPMV-1 zob.pigeon paramyxovirus type 1; pigeon paramyxovirus type 1; pigeon; reverse transcription polymerase chain reaction

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2014
• Tom: 70
• Numer: 04
• Opis fizyczny: p.219-223,fig.,ref.

Twórcy

autor

Stenzel T.

• Department of Poultry Diseases, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-719 Olsztyn, Poland

autor

Tykalowski B.

• Department of Poultry Diseases, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-719 Olsztyn, Poland

autor

Smialek M.

• Department of Poultry Diseases, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-719 Olsztyn, Poland

autor

Pestka D.

• Department of Poultry Diseases, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-719 Olsztyn, Poland

autor

Koncicki A.

• Department of Poultry Diseases, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-719 Olsztyn, Poland

Bibliografia

• 1. Barbezange C., Jestin V.: Development of a RT-nested PCR test detecting pigeon Paramyxovirus-1 directly from organs of infected animals. J. Virol. Meth. 2002, 106, 197-207.
• 2. Barbezange C., Jestin V.: Molecular Characterization of Three Avian Paramyxovirus Type 1 Isolated from Pigeons in France. Virus Genes 2003, 26, 175-183. B.
• 3. Barbezange C., Jestin V.: Molecular study of the quasispecies evolution of a typical pigeon paramyxovirus type 1 after serial passages in pigeons by contact. Avian Pathol. 2005, 34, 111-122.
• 4. Barbezange C., Jestin V.: Monitoring of pigeon paramyxovirus type-1 in organs of pigeons naturally infected with Salmonella Typhimurium. Avian Pathol. 2003, 32, 277-283. A.
• 5. Cerník K., Tůmová B., Kaminskýj B., Rajtár V.: Serologic detection of the occurrence of avian paramyxoviruses in pigeons. Vet. Med. (Praha) 1985, 30, 603-610.
• 6. Cerník K., Tůmová B., Novotná L., Kaminskýj B., Rajtár V.: Characteristics of paramyxoviruses isolated from pigeons in Czechoslovakia. Vet. Med. (Praha) 1985, 30, 103-117.
• 7. Creelan J. L., Graham D. A., McCullough S. J.: Detection and differentiation of pathogenicity of avian paramyxovirus serotype 1 from field cases using one-step reverse transcriptase-polymerase chain reaction. Avian Pathol. 2002, 31, 493-499.
• 8. Ginsberg T., Glasky A. J.: Inosiplex: an immunomodulation model for the treatment of viral diseases. Ann. NY Acad. Sci. 1977, 284, 128-138.
• 9. Gordon P., Brown E. R.: The antiviral activity of Isoprinosine. Can. J. Microbiol. 1972, 18, 1463-1470.
• 10. Hadden W. J., Lopez R., O’Reilly J., Hadden E. M.: Levamisole and Inosiplex: antiviral agents with immunopotentiating action. Ann. NY Acad. Sci. 1977, 284, 139-152.
• 11. Meulemans G., van den Berg T. P., Decasstecker M., Boschmans M.: Evolution of pigeon Newcastle disease virus strains. Avian Pathol. 2002, 31, 515-519.
• 12. Moya P., Alonso M. L., Baixeras E., Ronda E.: Immunomodulatory activity of Isoprinosine on experimental viral infections in avian models. Int. J. Immunopharmacol. 1984, 6, 339-343.
• 13. Ohnishi H., Kosuzume H., Inaba H., Ohkura M., Shimada S., Suzuki Y.: The immunomodulatory action of inosiplex in relation to its effects in experimental viral infections. Int. J. Immunopharmacol. 1983, 5, 181-196.
• 14. Siwicki A. K., Pozet F., Morand M., Kazuń B., Trapkowska S.: In vitro effect of methisoprinol on salmonid Rhabdoviruses replication. Bull. Vet. Inst. Pulawy 2002, 46, 53-58.
• 15. Stenzel T., Tykałowski B., Śmiałek M., Kwiatkowska-Stenzel A., Koncicki A.: The effect of different doses of methisoprinol on the percentage of CD4⁺ and CD8⁺ T lymphocyte subpopulation and the antibody titers in pigeons immunised against PPMV-1. P. J. Vet. Sci. 2011, in press.
• 16. Stenzel T., Pestka D., Tykałowski B., Śmiałek M., Koncicki A.: Epidemiological investigation of selected pigeon viral infections in Poland. Vet. Rec. 2012, 171, 562.
• 17. Śmietanka K.: Molekularna charakterystyka krajowych szczepów paramyksowirusów ptaków serotypu 1. Praca doktorska, Puławy 2007.
• 18. Śmietanka K., Minta Z., Domańska-Blicharz K., Majer-Dziedzic B., Pochodyła A.: Characterization of pigeon paramyxovirus type 1 strains isolated in Poland in 1988-2005. Bull. Vet. Inst. Pulawy 2006, 50, 283-286.